Gary B. Schneider, Ph.D.
Chief of Research
Gary B. Schneider, Ph.D., is Chief of Research at New England Baptist Hospital. In this role he serves as the research thought leader for the hospital and is a valuable resource for clinicians and staff. Additionally, Dr. Schneider provides clinical and analytic oversight to the Joint Registry, works with internal and external investigators to publish manuscripts using Registry data, and oversees the annual fellows’ research training program.
Dr. Schneider has published more than 58 peer-reviewed articles, and is currently a consultant reviewer for the Journal of Bone and Mineral Research. He has given many scientific presentations both nationally and internationally and is a member of numerous professional societies, including the American Association for the Advancement of Science, American Society for Bone and Mineral Research, American Society for Cell Biology and International Bone and Mineral Society.
Dr. Schneider’s previous faculty appointments have been in departments of cell biology and orthopedic surgery. For over 25 years, he was continuously funded by the NIH to conduct research programs involving stem cell transplantation, drug discovery and gene therapy as potential treatments for a number of bone diseases and skeletal disorders. An inventor, he holds multiple patents related to musculoskeletal diseases and has worked with a wide range of businesses on the development of new technologies in the fields of human stem cells, drug discovery and medical devices. He has served on a number of National Institutes of Health study sections and special emphasis panels as well as National Research Council and National Science Foundation review groups.
After receiving a Bachelor of Science degree in Zoology from the University of Wisconsin-Madison, Dr. Schneider earned his Ph.D in Biochemistry from the cooperative five-college program (Amherst, Hampshire, Mt. Holyoke, Smith College, and UMass-Amherst).
Dr. Schneider joined NEBH in February of 2012 from the University of Massachusetts Medical School where he served as the Associate Vice Provost for Research and the Director of the Office of Research Integration for the UMass Center for Clinical and Translational Research. His primary research interests are in bone cell biology and musculoskeletal clinical trials.